Adaptive two-stage optimal designs for phase II clinical studies that allow early futility stopping
Adaptive designs play an important role in contemporary clinical trials to make designs flexible and efficient. In cancer clinical trials, given a relatively small sample size, it is important to obtain as much information as possible during this phase. We propose a new adaptive optimal design that...
Saved in:
Published in | Sequential analysis Vol. 38; no. 2; pp. 199 - 213 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia
Taylor & Francis
03.04.2019
Taylor & Francis Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!